Rezultati pretrage autora :: Library Catalog

1

Figure 4 from In Vivo Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma od Nicholas T. Younger (14956251)

Izdano 2025
Daljnji autori:

Spremi u popis

Spremljeno u:
2

Figure 1 from In Vivo Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma od Nicholas T. Younger (14956251)

Izdano 2025
Daljnji autori:

Spremi u popis

Spremljeno u:
3

Figure 2 from In Vivo Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma od Nicholas T. Younger (14956251)

Izdano 2025
Daljnji autori:

Spremi u popis

Spremljeno u:
4

Figure 3 from In Vivo Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma od Nicholas T. Younger (14956251)

Izdano 2025
Daljnji autori:

Spremi u popis

Spremljeno u:
5

Table 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification od Robert L. Hollis (15034814)

Izdano 2025
Daljnji autori: “…Alison M. Meynert (14956260)…”

Spremi u popis

Spremljeno u:
6

Figure 4 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification od Robert L. Hollis (15034814)

Izdano 2025
Daljnji autori: “…Alison M. Meynert (14956260)…”

Spremi u popis

Spremljeno u:
7

Figure 3 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification od Robert L. Hollis (15034814)

Izdano 2025
Daljnji autori: “…Alison M. Meynert (14956260)…”

Spremi u popis

Spremljeno u:
8

Figure 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification od Robert L. Hollis (15034814)

Izdano 2025
Daljnji autori: “…Alison M. Meynert (14956260)…”

Spremi u popis

Spremljeno u:
9

Figure 5 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification od Robert L. Hollis (15034814)

Izdano 2025
Daljnji autori: “…Alison M. Meynert (14956260)…”

Spremi u popis

Spremljeno u:
10

Figure 2 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification od Robert L. Hollis (15034814)

Izdano 2025
Daljnji autori: “…Alison M. Meynert (14956260)…”

Spremi u popis

Spremljeno u:

Figure 4 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma od Nicholas T. Younger (14956251)

Figure 1 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma od Nicholas T. Younger (14956251)

Figure 2 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma od Nicholas T. Younger (14956251)

Figure 3 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma od Nicholas T. Younger (14956251)

Table 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification od Robert L. Hollis (15034814)

Figure 4 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification od Robert L. Hollis (15034814)

Figure 3 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification od Robert L. Hollis (15034814)

Figure 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification od Robert L. Hollis (15034814)

Figure 5 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification od Robert L. Hollis (15034814)

Figure 2 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification od Robert L. Hollis (15034814)

Figure 4 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma od Nicholas T. Younger (14956251)

Figure 1 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma od Nicholas T. Younger (14956251)

Figure 2 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma od Nicholas T. Younger (14956251)

Figure 3 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma od Nicholas T. Younger (14956251)

Table 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification od Robert L. Hollis (15034814)

Figure 4 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification od Robert L. Hollis (15034814)

Figure 3 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification od Robert L. Hollis (15034814)

Figure 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification od Robert L. Hollis (15034814)

Figure 5 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification od Robert L. Hollis (15034814)

Figure 2 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification od Robert L. Hollis (15034814)

Alati za pretragu: